Recently, Huzhou Puyuan Biotechnology Co., Ltd. received tens of millions of financing from chizi fund, and this round of financing is exclusively invested by chizi fund. This round of financing funds will be mainly used to build new R & D bases and expand sales channels.
Mass spectrometry is a kind of analytical method for separating and detecting charged substances. It is a universal method with high specificity, high sensitivity and multi index analysis at the same time. It can provide the molecular weight and rich structural information of the substances to be measured. It is applied in clinical medicine, drug development, industry, atmospheric environment, aerospace and other fields. The ions produced by matrix assisted laser desorption mass spectrometry (MALDI) are often detected by time-of-flight detectors, so MALDI-TOF mass spectrometry is very suitable for the study of biological macromolecules such as proteins, peptides, nucleic acids and polysaccharides.
Puyuan biology is a technology company focusing on the research, development, production, sales and service of”MALDI-TOF MS” full-automatic instruments, equipment, consumables and solutions. The company cooperates with China Academy of metrology, China Agricultural University, Chinese Academy of Sciences, Shandong University and other scientific research institutions to carry out scientific and technological innovation research and development projects. At present, sub centers for research and development, production, application development, sales and service have been set up in Canada, Singapore, South Korea, Beijing, Jinan, Hangzhou, Huzhou and other places. At present, the company has two technical platforms,”automated MALDI-TOF MS” and”microbial identification and nucleic acid detection chip”, and has developed a series of technologies such as microbial mass spectrometry system, nucleic acid mass spectrometry system, rapid detection system of foodborne pathogenic bacteria, and the application fields have gradually expanded to clinical medicine, inspection and quarantine, food safety, disease control, etc.
Pure funds is a leading research driven venture capital institution. Founded in 2015 and headquartered in Hangzhou, China, it focuses on early investment in intelligent manufacturing, artificial intelligence, new energy and materials, biotechnology and new drug research and development, entertainment and sports, and is committed to becoming the earliest and most important investor in many high growth entrepreneurial enterprises in China